ArmaGen, Inc   Report issue

For profit Phase 1 Phase 2
Founded: Santa Monica CA United States (2001)
Status: Acquired by JCR Pharmaceuticals Co., Ltd. (2020)

Organization Overview

First Clinical Trial
2015
NCT02262338
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

agt-181 (4 trials)

Drugs in Phase 1 Trials (1)

agt-182 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Mucopolysaccharidoses (Phase 2)

Mucopolysaccharidosis I (Phase 2)

Mucopolysaccharidosis II (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 2